0001567619-20-004369.txt : 20200219
0001567619-20-004369.hdr.sgml : 20200219
20200219213259
ACCESSION NUMBER: 0001567619-20-004369
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200214
FILED AS OF DATE: 20200219
DATE AS OF CHANGE: 20200219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: POLEWACZYK JAMES F
CENTRAL INDEX KEY: 0001389046
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19271
FILM NUMBER: 20632366
MAIL ADDRESS:
STREET 1: IDEXX LABORATORIES, INC.
STREET 2: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE
CENTRAL INDEX KEY: 0000874716
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 010393723
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
BUSINESS PHONE: 2075560300
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
FORMER COMPANY:
FORMER CONFORMED NAME: IDEXX CORP / DE
DATE OF NAME CHANGE: 19600201
4
1
doc1.xml
FORM 4
X0306
4
2020-02-14
0
0000874716
IDEXX LABORATORIES INC /DE
IDXX
0001389046
POLEWACZYK JAMES F
ONE IDEXX DRIVE
WESTBROOK
ME
04092
0
1
0
0
Executive Vice President
Common Stock
2020-02-14
4
M
0
207
0
A
16106
D
Common Stock
2020-02-14
4
M
0
243
0
A
16349
D
Common Stock
2020-02-14
4
M
0
150
0
A
16499
D
Common Stock
2020-02-14
4
M
0
126
0
A
16625
D
Common Stock
2020-02-14
4
M
0
127
0
A
16752
D
Common Stock
2020-02-14
4
F
0
259
288.78
D
16493
D
Non-Qualified Stock Option (right-to-buy)
288.78
2020-02-14
4
A
0
8906
A
2030-02-13
Common Stock
8906
8906
D
Restricted Stock Unit
2020-02-14
4
A
0
866
A
Common Stock
866
3147
D
Restricted Stock Unit
2020-02-14
4
M
0
207
D
Common Stock
2940
2940
D
Restricted Stock Unit
2020-02-14
4
M
0
243
D
Common Stock
243
2697
D
Restricted Stock Unit
2020-02-14
4
M
0
150
D
Common Stock
150
2547
D
Restricted Stock Unit
2020-02-14
4
M
0
126
D
Common Stock
126
2421
D
Restricted Stock Unit
2020-02-14
4
M
0
127
D
Common Stock
127
2294
D
Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2021.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2016. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2017.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2018.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.
Not applicable.
/s/ Lily J. Lu, Attorney-in-Fact for James F. Polewaczyk
2020-02-19